A recent study has found daily intake of aspirin can cut the risk of developing cancer. For the study, about 1, 00,000 people were recruited. Previous studies have also showed that the intake of aspirin reduce the incidences of cancer.
However, the recent study has proclaimed that patients can be prescribed aspirin as proactive drug. It has been found that doctors often advice patients above 50 years of age to take low dosage of aspirin.
The author of the study said, “Even a relatively modest benefit with respect to overall cancer mortality could still meaningfully influence the balances of risks and benefits of prophylactic (protective) aspirin use”.
The findings of the study have been published in the American Cancer Society. However, researchers are again and again asking for more studies into the usefulness of aspirin in warding off the risk of cancer.
However, doctors are fearful that regular intake of aspirin can cause gastrointestinal bleeding. It has been recommended that the decision of taking aspirin should be taken by keeping in mind the risk and benefits involved in having aspirin. Further studies would be conducted on aspirin’s usefulness so that it could be prescribed to potential patients.
- Increase in Number of Unpaid and Young Carers
- New Cancer Drug Compounds Moved Forward to Phase-III Development
- Health Bosses Ensure Staff Vaccination against Measles in Wake of Likely Outbreak
- Bea Arthur’s nude painting sells for $1.9 million at Christie’s auction
- Zoe Saldana seen kissing former Italian footballer Perego